Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. UAMY
UAMY logo

UAMY Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy United States Antimony Corp (UAMY) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
7.850
1 Day change
2.48%
52 Week Range
19.710
Analysis Updated At
2026/06/12
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

UAMY is not a clear buy right now for a beginner long-term investor with $50,000-$100,000 available. The stock has supportive analyst coverage and a constructive long-term strategic theme around domestic antimony supply, but the current technical setup is weak and the latest price action is under pressure. Since the user is impatient and does not want to wait for an ideal entry, the direct view is to avoid initiating a full position here and wait for a stronger trend confirmation.

Technical Analysis

UAMY is trading at 7.18, down 2.11% on the day, with pre-market slightly negative as well. The MACD histogram is -0.171 and still below zero, indicating bearish momentum, though it is not worsening sharply. RSI_6 at 32.57 is near oversold but not yet a strong reversal signal. Moving averages are converging, which often precedes a directional move, but the current setup is not yet bullish. Price is sitting just above the first support at 7.021, with resistance at 8.362, so the near-term structure suggests the stock is more likely consolidating than breaking out. The historical pattern forecast also implies limited near-term upside and potential weakness over the next month.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Options sentiment is bullish overall. The put-call ratios are low, showing call-heavy positioning and suggesting traders are leaning positive on the name. Total call open interest of 235,665 versus put open interest of 67,833 reinforces that bias. However, implied volatility remains very high at 114.15, with historical volatility at 119.89, so the options market expects large swings. Volume is also elevated versus recent averages, which signals active speculation rather than calm conviction. The options data is supportive, but it does not override the weak technical picture.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
6
Buy
4

Positive Catalysts

  • ["Analyst firms continue to rate the stock Buy.", "Price targets have been raised recently, from $10.25 to $11.50, then to $13 and later to $11.75.", "The company benefits from strategic interest in domestic antimony supply.", "U.S. policy support for critical minerals is a favorable backdrop for the business."]

Neutral/Negative Catalysts

  • ["The stock is down on the day and below short-term momentum confirmation.", "MACD remains negative, signaling weak trend strength.", "Near-term price structure is sitting close to support, not in a breakout zone.", "No meaningful insider or hedge fund accumulation trend is visible.", "No recent congress trading data was available.", "Recent news flow in the provided data is about a peer company, not a direct bullish company-specific catalyst for UAMY."]

Financial Performance

No usable latest-quarter financial snapshot was provided because the financial data section returned an error. So there is no reliable quarter-by-quarter revenue or earnings trend to assess here. Based on the available information, the investment case is being driven more by strategic positioning, analyst optimism, and market sentiment than by reported quarter fundamentals in this dataset.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analyst sentiment is positive. H.C. Wainwright raised its target to $11.75 from $11.50 and kept a Buy rating after Q1. B. Riley raised its target to $13 from $11 and also kept a Buy rating, citing expanded feedstock procurement and domestic antimony supply priority despite a near-term delay at Thompson Falls. H.C. Wainwright earlier also lifted its target to $11.50 from $10.25 following 2025 results. Wall Street's pros view is that UAMY has strategic upside tied to U.S. antimony supply and production growth. The cons view is that execution timing has been uneven and the stock lacks strong current momentum.

Wall Street analysts forecast UAMY stock price to rise
3 Analyst Rating
Wall Street analysts forecast UAMY stock price to rise
3 Buy
0 Hold
0 Sell
Strong Buy
Current: 7.660
sliders
Low
9.75
Averages
10
High
10.25
Current: 7.660
sliders
Low
9.75
Averages
10
High
10.25
H.C. Wainwright
Heiko Ihle
Buy
maintain
AI Analysis
2026-05-18
Reason
H.C. Wainwright
Heiko Ihle
Price Target
AI Analysis
2026-05-18
maintain
Buy
Reason
H.C. Wainwright analyst Heiko Ihle raised the firm's price target on United States Antimony to $11.75 from $11.50 and keeps a Buy rating on the shares. The firm updated the company's model post the Q1 report.
B. Riley
Nick Giles
Buy
maintain
$11 -> $13
2026-03-24
Reason
B. Riley
Nick Giles
Price Target
$11 -> $13
2026-03-24
maintain
Buy
Reason
B. Riley analyst Nick Giles raised the firm's price target on United States Antimony to $13 from $11 and keeps a Buy rating on the shares. While the delay of the Thompson Falls expansion is a near-term "blemish," the price target is being raised due to the increased scope of feedstock procurement and the continued prioritization of domestic antimony supply, the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for UAMY
Unlock Now

People Also Watch